JDD

JDD Buzz Series | DermTok: Who’s Talking Sun?
sun protectionTikTok is a source of beauty and skin health information for the masses. Yet much of the content is not produced by board-certified dermatologists or even other healthcare professionals. So who’s creating TikTok content about sun protection and skin cancer? Does any of this content address skin of color? Those are the questions a new cross-sectional analysis published in the July Journal of Drug …
sun protection
JDD July 2024 Issue Highlights
JDDThis July, the Journal of Drugs in Dermatology (JDD) is proud to present a special edition focused on "Bridging the Gap in Dermatology." Our Editor's Picks this month highlight groundbreaking research and discussions aimed at promoting inclusivity, representation, and innovation in dermatologic care. From advancements in sun protection to the role of social media in healthcare, these pieces provid …
JDD
Urticaria Pigmentosa Without Pruritus | Case Report
urticaria pigmentosa Mastocytosis is a group of disorders characterized by the pathologic accumulation of mast cells in various tissues. One example of mastocytosis is urticaria pigmentosa, which presents with mastocytomas that can cause hives and, when irritated, pruritus. To the authors' knowledge, they are describing the first case of urticaria pigmentosa without pruritus. The patient had a positive Darier' …
urticaria pigmentosa
JDD Buzz Series | Sunscreen Practices & Preferences in Skin of Color Patients
sunscreen usageSunscreen use varies among different racial groups despite its scientifically proven benefits. A cross-sectional, questionnaire-based study in the June issue of the Journal of Drugs in Dermatology aims to understand the needs and challenges people with skin of color face when choosing and using sunscreen. I interviewed author Jared Jagdeo, MD, MS, associate professor of dermatology and director …
sunscreen usage
Ruxolitinib 1.5% Topical Cream for the Treatment of Pediatric Alopecia Areata | Case Report
pediatric alopeciaAlopecia areata (AA) is a common autoimmune disorder. Although its pathogenesis is not fully understood, AA involves CD8 T cell-mediated destruction of the hair follicle. Several treatment options exist; however, there is minimal evidence in the pediatric population. Currently, there are no curative treatments for AA. The literature suggests that Janus kinase (JAK) inhibitors may be an effective t …
pediatric alopecia